PUBLICATION EXCLUSIVE: When will eye drops stop rolling down our faces?

For as long as I have been performing cataract surgery, there are three real reasons for the use of mainstay topical therapy after cataract surgery: to eliminate pain and inflammation, to prevent cystoid macular edema and to prevent any type of infection.Although mainstay topical eye drop therapy has become more advanced from once-daily dosing to unique delivery systems that rely less on patient shaking (emulsions, gels, DuraSite from InSite Vision) to more potency with modification of quinolones (besifloxacin based on in vitro ARMOR surveillance data), there still remains many problems (Read more...)

Full Story →